Health Condition 1: F32- Major depressive disorder, singleepisode
Conditions
Interventions
Intervention1: Vortioxetine: Vortioxetine will be started at a dose of 10 mg once daily
and increased to 20 mg/day after 2 weeks.
Control Intervention1: Escitalopram: Escitalopram will be started at a
Sponsors
Ahana Hospitals LLP
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are meeting International Classification of Diseases 10 criteria for major depressive disorder Patients who gave informed written consent.
Exclusion criteria
Exclusion criteria: Patients with other comorbid psychiatric disorder (except major depressive disorder) Patients who were having comorbid substance dependence Patients with any other medical disorder which is confounding our inclusion diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 17-item Hamilton Depression Scale (HAM-D17) done at baseline, 2nd week, 4th week and 12th weeksTimepoint: 17-item Hamilton Depression Scale (HAM-D17) done at baseline, 2nd week, 4th week and 12th weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| CGI- severity of illness (CGI-S) and improvement scale (CGI-I) done at baseline, 2nd week, 4th week and 12th weekTimepoint: CGI- severity of illness (CGI-S) and improvement scale (CGI-I) done at baseline, 2nd week, 4th week and 12th week | — |
Countries
India
Contacts
Public ContactVikhram Ramasubramanian
Ahana hospitals, LLP
Outcome results
None listed